IVP 📈 Inspire Veterinary - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
IVP: Veterinary, Hospitals, Healthcare, Surgical, Preventive, Wellness, Animal
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. It also offers surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. The company was incorporated in 2020 and is based in Virginia Beach, Virginia. Web URL: https://www.inspirevet.com
Additional Sources for IVP Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IVP Stock Overview
Market Cap in USD | 6m |
Sector | Consumer Cyclical |
Industry | Personal Services |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2023-08-30 |
IVP Stock Ratings
Growth 5y | -76.6% |
Fundamental | -44.8% |
Dividend | - |
Rel. Strength Industry | -2033 |
Analysts | - |
Fair Price Momentum | 0.18 USD |
Fair Price DCF | - |
IVP Dividends
No Dividends PaidIVP Growth Ratios
Growth Correlation 3m | -89.7% |
Growth Correlation 12m | -88.9% |
Growth Correlation 5y | -95.1% |
CAGR 5y | -99.63% |
CAGR/Mean DD 5y | -1.08 |
Sharpe Ratio 12m | -0.93 |
Alpha | -118.70 |
Beta | 0.68 |
Volatility | 156.51% |
Current Volume | 1159.3k |
Average Volume 20d | 1473.9k |
What is the price of IVP stocks?
As of December 21, 2024, the stock is trading at USD 0.19 with a total of 1,159,286 shares traded.
Over the past week, the price has changed by +4.87%, over one month by -18.48%, over three months by -74.73% and over the past year by -99.46%.
As of December 21, 2024, the stock is trading at USD 0.19 with a total of 1,159,286 shares traded.
Over the past week, the price has changed by +4.87%, over one month by -18.48%, over three months by -74.73% and over the past year by -99.46%.
Is Inspire Veterinary a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Inspire Veterinary (NASDAQ:IVP) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.80 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IVP as of December 2024 is 0.18. This means that IVP is currently overvalued and has a potential downside of -5.26%.
Probably not. Based on ValueRay Fundamental Analyses, Inspire Veterinary (NASDAQ:IVP) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.80 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IVP as of December 2024 is 0.18. This means that IVP is currently overvalued and has a potential downside of -5.26%.
Is IVP a buy, sell or hold?
Inspire Veterinary has no consensus analysts rating.
Inspire Veterinary has no consensus analysts rating.
What are the forecast for IVP stock price target?
According to ValueRays Forecast Model, IVP Inspire Veterinary will be worth about 0.2 in December 2025. The stock is currently trading at 0.19. This means that the stock has a potential upside of +5.26%.
According to ValueRays Forecast Model, IVP Inspire Veterinary will be worth about 0.2 in December 2025. The stock is currently trading at 0.19. This means that the stock has a potential upside of +5.26%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.2 | 5.3% |